Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study.

MLA

Basude, S., et al. “Low-Molecular-Weight Heparin or Warfarin for Anticoagulation in Pregnant Women with Mechanical Heart Valves: What Are the Risks? A Retrospective Observational Study.” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 119, no. 8, July 2012, pp. 1008–13. EBSCOhost, https://doi.org/10.1111/j.1471-0528.2012.03359.x.

APA

Basude, S., Hein, C., Curtis, S., Clark, A., & Trinder, J. (2012). Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study. BJOG: An International Journal of Obstetrics & Gynaecology, 119(8), 1008–1013. https://doi.org/10.1111/j.1471-0528.2012.03359.x

Chicago

Basude, S, C Hein, Sl Curtis, A Clark, and J Trinder. 2012. “Low-Molecular-Weight Heparin or Warfarin for Anticoagulation in Pregnant Women with Mechanical Heart Valves: What Are the Risks? A Retrospective Observational Study.” BJOG: An International Journal of Obstetrics & Gynaecology 119 (8): 1008–13. doi:10.1111/j.1471-0528.2012.03359.x.